Business & Economy
AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
Source: Business News · Published
Pascal Soriot spoke exclusively with CNBC from the site of AstraZeneca's new $1 billion R&D facility in Kendall Square in Cambridge, Massachusetts.
Pascal Soriot spoke exclusively with CNBC from the site of AstraZeneca's new $1 billion R&D facility in Kendall Square in Cambridge, Massachusetts.
Related stories
Lucid's Q3 deliveries fall 6.7% as EV maker cuts production to align with demand
Lucid delivered 3,806 EVs and produced 2,954 vehicles during the third quarter. That compared with 4,078 deliveries on production of 3,891 vehicles a year earlier.
Business News ·
US supreme court hears big oil’s bid to block climate damage lawsuits
How court will lean is unclear amid Suncor Energy and ExxonMobil’s attempt to stop lawsuits at state level The US supreme court began its new nine-month term hearing arguments on Monday in a major case in which big oil companies attempted to strike a fatal blow against lawsuits t
Business | The Guardian ·
Gatorade maker recalls 122,000 cases of popular sports drink across 37 US states
PepsiCo initiated class II recall of 28oz bottles last month over ‘undeclared’ yellow dyes, FDA notice says About 122,000 cases of the popular sports drink Gatorade have been voluntarily recalled across 37 US states due to their having “undeclared” food dye, according to an offic
Business | The Guardian ·
These are the cheapest and most expensive U.S. flights this November
Holiday airplane tickets are up more than 23% this year, according to Hopper.
Business News ·
Conservative plans to slash aid budget would ‘irreparably damage’ UK’s global credibility, charities say
Party’s pledge to reduce aid budget from £9bn a year to £1bn to fund new prison places branded as ‘posturing’ Conservative plans to slash the aid budget by 90% would leave the UK unable to cover existing contributions to the UN and World Bank and “irreparably damage” Britain’s gl
Business | The Guardian ·